Market Tracker

08/03 8:55am ET

PDL BioPharma Inc (NASDAQ:PDLI)

5.82
Delayed Data
As of Jul 31
 +0.06 / +1.04%
Today’s Change
5.71
Today|||52-Week Range
10.26
-24.51%
Year-to-Date

Today’s Trading

Previous close5.76
Today’s open5.77
Day’s range-- - --
Volume2,172,458
Average volume (3 months)2,646,476
Market cap$955.0M
Dividend yield10.31%
Data as of 07/31/2015

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)+11.29%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+31.23%
P/E ratio3.0
Price/Sales2.30
Price/Book2.05

Competitors

 Today’s
change
Today’s
% change
FLMLFlamel Technologies ...+0.04+0.17%
ENTAEnanta Pharmaceutica...+1.01+2.03%
ARNAArena Pharmaceutical...+0.07+1.76%
SCMPSucampo Pharmaceutic...+0.89+4.26%
Data as of 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$0.52
Annual revenue (last year)$581.2M
Annual profit (last year)$322.2M
Net profit margin55.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts